Do you want to read an article? Please log in or register.
Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study: A Post Hoc Exploratory Analysis of a Randomized Clinical Trial
Further Publications
Related content
Further Publications
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial
JAMA Ophthalmol
Lee WK, Wong TY, Chen SJ, Sun X, Cheung CMG, Silva R, Ricci F, Zhang X, Machewitz T, Schulze A, Schmidt-Ott UM, Zhao M, Hasanbasic Z, Leal S, Iida T, PULSAR Study Investigators
doi: 10.1001/jamaophthalmol.2025.5098
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819
Retinal DiseasesFurther Publications
Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1 Randomized Clinical Trial
JAMA Ophthalmol
Kay CN, Saad L, DeBartolomeo G, Bressler N, Tsang SH, Stepien K, Bernstein P, Lam BL, Washington I, Gorin MB, TEASE-1 Study Group
doi: 10.1001/jamaophthalmol.2026.3662
Dry Eye Disease
Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study
Am J Ophthalmol
Hori Y, Wada T, Omatsu K, SJP-0132 clinical study investigators
doi: 10.1016/j.ajo.2025.11.036
Cornea and Corneal DiseasesFurther Publications
Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical Trial
JAMA Ophthalmol
Lass JH, Benetz BA, Verdier DD, Szczotka-Flynn LB, Bauza CE, Reed ZW, Greiner MA, Mian SI, Patel SV, Pramanik S, Price FW Jr, Soper MC, Terry MA, Titus MS, Kollman C, Beck RW, Price MO, Diabetes Endothelial Keratoplasty Study Group
doi: 10.1001/jamaophthalmol.2025.4261
Surgery and Intervention
Chronic Hypotony After Tube Shunt Surgery: A Pooled Analysis of Data from Three Randomized Clinical Trials
Am J Ophthalmol
Gedde AY, Huertas L, O'Brien R, Christakis PG, Ahmed IIK, Vazquez LE, Han Y, Budenz DL, ABC, AVB, and TVT Study Groups
doi: 10.1016/j.ajo.2025.11.022
Glaucoma and Ocular Pressure
Factors Associated With Progression to Primary Angle Closure: A Post Hoc Analysis of the ANA-LIS Trial
JAMA Ophthalmol
Tun TA, Yoo C, Servillo A, Baskaran M, Kumar RS, Narayanaswamy A, Foster PJ, Friedman DS, Aung T
doi: 10.1001/jamaophthalmol.2026.2554
RECOMMENDED
Dry Eye Disease
Lifitegrast Ophthalmic Solution 5.0% (KH732) for Dry Eye Disease: A randomized, Multicenter, Double-Masked, vehicle-controlled Phase 3 Trial
★ 2
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ocul Surf
Lu Y, Jin X, Li X, Jie Y, Tao L, Ren S, Zhao S, Li Y, Xu G, Zhuang W, Li Y, Chen W, Cai S, Gu H, Zhang H, Li L, You Z, Li J, Zhao J, Chen Q, Huang T, Wu P, Wang T, Yao Y, Wang H, Li Z, Shu X, Wang R, Zhang M, Wen F, Fu Y, Pei C, Zhang W, Guan H, Zhao H, Yang J, Song L, He M, Lv X, Wu F, Gong L, Sun X
doi: 10.1016/j.jtos.2026.04.006
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007